Home > Insider Trading > Filing (0001596783-17-000027)

Filing Details

Accession Number:: 0001596783-17-000027
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-22 19:06:13
Reporting Period:: 2017-03-20

Filing Date:: 2017-03-22
Accepted Time:: 2017-03-22 19:06:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596783	Catalent Inc.	CTLT	Pharmaceutical Preparations (2834)	208737688

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1612228	William Downie	C/O Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-03-20	6,202	$18.71	34,604	No	4	M	Direct
Common Stock	Disposition	2017-03-20	5,054	$28.76	29,550	No	4	F	Direct
Common Stock	Disposition	2017-03-20	574	$28.60	28,976	No	4	S	Direct
Common Stock	Acquisiton	2017-03-20	1,031	$10.71	30,007	No	4	M	Direct
Common Stock	Disposition	2017-03-20	689	$28.76	29,318	No	4	F	Direct
Common Stock	Disposition	2017-03-20	171	$28.60	29,147	No	4	S	Direct
Common Stock	Acquisiton	2017-03-20	35,000	$10.71	64,147	No	4	M	Direct
Common Stock	Disposition	2017-03-20	23,416	$28.53	40,731	No	4	F	Direct
Common Stock	Disposition	2017-03-20	5,792	$28.60	34,939	No	4	S	Direct
Common Stock	Acquisiton	2017-03-20	10,122	$20.50	45,061	No	4	M	Direct
Common Stock	Disposition	2017-03-20	8,582	$28.76	36,479	No	4	F	Direct
Common Stock	Disposition	2017-03-20	770	$28.60	35,709	No	4	S	Direct
Common Stock	Acquisiton	2017-03-20	5,748	$10.71	41,457	No	4	M	Direct
Common Stock	Disposition	2017-03-20	3,837	$28.76	37,620	No	4	F	Direct
Common Stock	Disposition	2017-03-20	955	$28.60	36,665	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase Common Stock	Disposition	2017-03-20	6,202	$0.00	6,202	$18.71
Common Stock	Options to purchase Common Stock	Disposition	2017-03-20	1,031	$0.00	1,031	$10.71
Common Stock	Options to purchase Common Stock	Disposition	2017-03-20	35,000	$0.00	35,000	$10.71
Common Stock	Options to purchase Common Stock	Disposition	2017-03-20	10,122	$0.00	10,122	$20.50
Common Stock	Options to purchase Common Stock	Disposition	2017-03-20	5,748	$0.00	5,748	$10.71

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2014-06-25	2023-06-25	No	4	M	Direct
0	2010-10-23	2019-10-23	No	4	M	Direct
0	2010-10-23	2019-10-23	No	4	M	Direct
10,122	2015-07-30	2024-07-30	No	4	M	Direct
29,252	2010-10-23	2019-10-23	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2017 in order to implement a plan of financial diversification.
Includes restricted stock units.
Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
Represents shares sold pursuant to the Rule 10b5-1 trading plan in footnote 1.
These shares were sold in multiple transactions at prices ranging from $28.26 to $28.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On June 25, 2013, the reporting person was granted an option to purchase 31,010 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2014, 2015, 2016, 2017 and 2018.
On October 23, 2009, the reporting person was granted an option to purchase 105,000 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments beginning on October 23, 2010.
On October 23, 2009, the reporting person was granted an option to purchase 35,000 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments beginning on October 23, 2010.
On July 30, 2014, the reporting person was granted an option to purchase 20,244 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on July 30, 2015.
On October 23, 2009, the reporting person was granted an option to purchase 35,000 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments beginning on October 23, 2010.